Oakbrook Investments LLC cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 81.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,050 shares of the pharmacy operator’s stock after selling 31,700 shares during the quarter. Oakbrook Investments LLC’s holdings in Walgreens Boots Alliance were worth $512,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently added to or reduced their stakes in the business. Iowa State Bank boosted its holdings in Walgreens Boots Alliance by 100.1% in the second quarter. Iowa State Bank now owns 8,397 shares of the pharmacy operator’s stock valued at $658,000 after acquiring an additional 4,200 shares during the last quarter. Texan Capital Management boosted its holdings in Walgreens Boots Alliance by 1.4% in the second quarter. Texan Capital Management now owns 54,095 shares of the pharmacy operator’s stock valued at $4,236,000 after acquiring an additional 747 shares during the last quarter. Jacobs & Co. CA boosted its holdings in Walgreens Boots Alliance by 5.3% in the second quarter. Jacobs & Co. CA now owns 106,679 shares of the pharmacy operator’s stock valued at $8,354,000 after acquiring an additional 5,323 shares during the last quarter. Mn Services Vermogensbeheer B.V. lifted its stake in shares of Walgreens Boots Alliance by 508.6% during the second quarter. Mn Services Vermogensbeheer B.V. now owns 149,455 shares of the pharmacy operator’s stock worth $11,704,000 after purchasing an additional 124,898 shares in the last quarter. Finally, Horrell Capital Management Inc. lifted its stake in shares of Walgreens Boots Alliance by 2.4% during the second quarter. Horrell Capital Management Inc. now owns 28,691 shares of the pharmacy operator’s stock worth $2,247,000 after purchasing an additional 681 shares in the last quarter. 61.57% of the stock is owned by institutional investors.
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) traded up $0.60 during trading hours on Wednesday, hitting $68.49. The stock had a trading volume of 5,514,227 shares, compared to its average volume of 6,100,000. Walgreens Boots Alliance Inc has a one year low of $63.82 and a one year high of $88.00. The firm has a market cap of $67,850.00, a P/E ratio of 18.92, a PEG ratio of 1.16 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. During the same quarter in the prior year, the firm earned $1.10 EPS. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. research analysts expect that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current fiscal year.
Walgreens Boots Alliance announced that its board has initiated a share buyback plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.
The company also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.34%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 44.20%.
In related news, insider Stefano Pessina purchased 98,858 shares of the company’s stock in a transaction dated Monday, January 15th. The shares were acquired at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 14.80% of the company’s stock.
A number of research analysts have commented on the company. Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Tuesday. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a research note on Wednesday. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Needham & Company LLC reiterated a “buy” rating and issued a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. Finally, ValuEngine lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. Ten analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $85.05.
TRADEMARK VIOLATION NOTICE: “Oakbrook Investments LLC Has $512,000 Holdings in Walgreens Boots Alliance Inc (WBA)” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/02/15/oakbrook-investments-llc-sells-31700-shares-of-walgreens-boots-alliance-inc-wba-2.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.